Life Science News

RSS

Study demonstrates ability of cobas HPV Test to detect HPV-16, HPV-18 genotypes linked to cervical cancer

Roche announced that a study published online today in the American Journal of Clinical Pathology demonstrated the ability of the cobas HPV Test to individually detect HPV-16 and HPV-18, two of the highest risk HPV genotypes causing 70 percent of cervical cancer cases.

From Roche Diagnostics Limited 25 Feb 2011

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash.

From Thermo Fisher Scientific Inc. 24 Feb 2011

Roche receives DOD approval to provide remote service and support for its lab analyzers

Roche announced today that it has received approval from the U.S. Department of Defense to provide remote service and support for its lab analyzers at Womack Army Medical Center through the DOD's secure B2B gateway. Roche is the first in-vitro diagnostics manufacturer to be approved by the DOD for this remote access.

From Roche Diagnostics Limited 24 Feb 2011

Panasonic to offer new high definition patient room display for hospitals

Panasonic Solutions Company, provider of collaboration, information-sharing and decision-support solutions for healthcare, government and commercial enterprises, today announced it will offer a new high definition, 32", hospital-grade, patient room display later this year.

From PHC Europe B.V. 21 Feb 2011

Thermo Fisher Scientific extends tender offer for Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation for $118.50 per share in cash has been extended and will now expire at 12:00 midnight, New York City time, at the end of Thursday, April 7, 2011, unless further extended.

From Thermo Fisher Scientific Inc. 16 Feb 2011

PerkinElmer launches Spectrum Two infrared spectrometer

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of Spectrum Two™, a reliable infrared (FT-IR) spectrometer built upon decades of spectroscopy expertise. Part of a new platform of FT-IR spectrometers, Spectrum Two is designed specifically to perform rapid analytical measurements and is suited to a wide range of materials and markets.

From PerkinElmer 14 Feb 2011

PerkinElmer announces acquisition of chemagen Biopolymer-Technologie

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.

From PerkinElmer 14 Feb 2011

Waitt Advanced Biophotonics Center opens at Salk Institute for Biological Studies

The Waitt Advanced Biophotonics Center at the Salk Institute for Biological Studies officially opened on February 9, 2011 after quietly hiring two faculty members specializing in biophotonics -- the science of using and manipulating light to investigate biological function -- and building up its core facility's imaging capacity to rival most if not all academic research institutions of its size in the nation.

From Olympus Life Science Solutions 14 Feb 2011

PerkinElmer announces launch of Frontier Infrared Spectrometer

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the FrontierTM Infrared Spectrometer, a high performance infrared spectrometer built using PerkinElmer's industry-leading spectroscopy expertise.

From PerkinElmer 11 Feb 2011

Thermo Fisher Scientific 2010 revenues increase 7% to $10.79 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2010.

From Thermo Fisher Scientific Inc. 2 Feb 2011

PerkinElmer announces release of 200th umbilical cord blood stem cell unit

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that its family cord blood banking business, ViaCord, has released its 200th umbilical cord blood stem cell unit for treatment purposes. The 200th unit will be used in a clinical trial intended to treat cerebral palsy with a re-infusion of a child's own umbilical cord stem cells.

From PerkinElmer 1 Feb 2011

FDA grants pre-market clearance for SBi's rHead Extended Stem

Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.

From Olympus Life Science Solutions 24 Jan 2011

PerkinElmer introduces next generation DNA sequencing and data analysis services

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease.

From PerkinElmer 24 Jan 2011

inVentiv Health to acquire Campbell Alliance and i3

inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.

From Thermo Fisher Scientific Inc. 21 Jan 2011

Thermo Fisher Scientific announces extension of tender offer for Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation for $118.50 per share in cash ("the Offer") has been extended and will now expire at 12:00 midnight, New York City time, at the end of Wednesday, February 16, 2011, unless further extended.

From Thermo Fisher Scientific Inc. 14 Jan 2011

Affymetrix enters distribution agreement with Fisher Scientific for GeneAtlas System

Affymetrix, Inc. today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its related consumables through the Fisher Scientific channel throughout the United States and Canada.

From Thermo Fisher Scientific Inc. 12 Jan 2011

Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to its offer to acquire Dionex (NASDAQ: DNEX).

From Thermo Fisher Scientific Inc. 10 Jan 2011

Thermo Fisher Scientific acquires Lomb Scientific

Thermo Fisher Scientific Inc., the world leader in serving science, has completed its previously announced acquisition of Lomb Scientific, a well-known provider of laboratory chemicals, consumables and instruments in Australia and New Zealand.

From Thermo Fisher Scientific Inc. 27 Dec 2010

Bruker closes Sigma ElectroOptics acquisition

Bruker today announced the signing of an agreement with simultaneous closing of the acquisition of Sigma ElectroOptics GmbH ('Sigma'), based in Hamburg, Germany. Sigma's 2010 revenue is expected to be about one million Euro (approximately $1.3 million). Financial details of the transaction were not disclosed. Sigma will be integrated into the Bruker Optics infrared and Raman spectroscopy division in Ettlingen, Germany.

From Bruker Optics 22 Dec 2010

Roche launches new xCELLigence System RTCA HT Instrument

The new xCELLigence System RTCA HT Instrument from Roche Diagnostics rounds out the company's portfolio in real-time cell analysis with a high-throughput product. The new instrument merges the power and flexibility of xCELLigence System technology with high-throughput analyses and workflows for automated screening applications.

From Roche Diagnostics Limited 14 Dec 2010